Dayang Chem (Hangzhou) Co., Ltd.
China
Product Name: 4,5-Dihydro-N-((4-bromophenyl)methyl)thiazolamine
Price: $Inquiry/100g $Inquiry/1kg $Inquiry/100kg $Inquiry/1000kg
Purity: 98.0%
Stocking Period: Inquiry
Contact: Ms Wang

72239-31-7

72239-31-7 structure

72239-31-7 structure

Name: 4,5-Dihydro-N-((4-bromophenyl)methyl)thiazolamine
Chemical Name: N-[(4-bromophenyl)methyl]-4,5-dihydro-1,3-thiazol-2-amine
CAS Number: 72239-31-7
Molecular Formula: C₁₀H₁₁BrN₂S
Molecular Weight: 271.17700
Create Date: 2017-06-08 16:30:20
Modify Date: 2024-01-22 12:29:22

Name	N-[(4-bromophenyl)methyl]-4,5-dihydro-1,3-thiazol-2-amine
Synonyms	(4-bromo-benzyl)-(4,5-dihydro-thiazol-2-yl)-amine 4,5-Dihydro-N-((4-bromophenyl)methyl)thiazolamine Thiazolamine,4,5-dihydro-N-((4-bromophenyl)methyl)

Density	1.56g/cm3
Boiling Point	390.1ºC at 760 mmHg
Molecular Formula	C₁₀H₁₁BrN₂S
Molecular Weight	271.17700
Flash Point	189.7ºC
Exact Mass	269.98300
PSA	49.69000
LogP	2.46800
Index of Refraction	1.674

CHEMICAL IDENTIFICATION

RTECS NUMBER :: XJ1263500

CHEMICAL NAME :: Thiazolamine, 4,5-dihydro-N-((4-bromophenyl)methyl)-

CAS REGISTRY NUMBER :: 72239-31-7

LAST UPDATED :: 199612

DATA ITEMS CITED :: 1

MOLECULAR FORMULA :: C10-H11-Br-N2-S

MOLECULAR WEIGHT :: 271.20

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: >80 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: EJMCA5 European Journal of Medicinal Chemistry--Chimie Therapeutique. (Editions Scientifiques Elsevier, 29 rue Buffon, F-75005, Paris, France) V.9- 1974- Volume(issue)/page/year: 14,553,1979

72225-20-8 structure

72225-20-8

~%

72239-31-7 structure

72239-31-7

Literature: Viallet; Boucherle; Cohen-Addad European Journal of Medicinal Chemistry, 1979 , vol. 14, # 6 p. 553 - 559

586-75-4 structure

586-75-4

~%

72239-31-7 structure

72239-31-7

Literature: Viallet; Boucherle; Cohen-Addad European Journal of Medicinal Chemistry, 1979 , vol. 14, # 6 p. 553 - 559